SCHEMBL24252239

SCHEMBL24252239

c1ccc(-n2c3ccccc3c3cc(-c4nc(-c5ccc(-c6cccnc6)cc5)cc(-c5cccc(-c6cccnc6)c5)n4)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.44
▸ CYP19A1 P11511 2/20 0.41
▸ KMO O15229 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ CYP17A1 P05093 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ PGR P06401 1/20 0.37
▸ GLA P06280 1/20 0.36
▸ KDR P35968 1/20 0.35
▸ TEK Q02763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252574 0.95 CYP19A1 (0.47) DHODHCYP19A1KMOMAPTCYP11B1
SCHEMBL17853514 0.95 DHODH (0.46) DHODHCYP19A1MAPTCYP11B1CYP11B2
SCHEMBL17853527 0.95 DHODH (0.46) DHODHCYP19A1MAPTCYP11B1CYP11B2
SCHEMBL19486661 0.94 DHODH (0.44) DHODHCYP19A1MAPTCYP11B1CYP11B2
SCHEMBL19486911 0.94 DHODH (0.44) DHODHCYP19A1MAPTCYP11B1CYP11B2
SCHEMBL17853555 0.94 DHODH (0.46) DHODHCYP19A1MAPTCYP11B1CYP11B2
SCHEMBL17853566 0.93 DHODH (0.47) DHODHCYP19A1KMOMAPTCYP11B1
SCHEMBL22113764 0.92 DHODH (0.44) DHODHCYP19A1KMOMAPTCYP11B1
SCHEMBL19397486 0.92 DHODH (0.44) DHODHCYP19A1KMOMAPTCYP11B1
SCHEMBL17853490 0.91 DHODH (0.45) DHODHCYP19A1KMOMAPTCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC29A1, NUDT1, SLC29A2 DHODH 202/4885CYP19A1 2810/4885KMO 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback